299 related articles for article (PubMed ID: 27586843)
1. Selective Modulator of Cannabinoid Receptor Type 2 Reduces Memory Impairment and Infarct Size During Cerebral Hypoperfusion and Vascular Dementia.
Jayant S; Sharma B
Curr Neurovasc Res; 2016; 13(4):289-302. PubMed ID: 27586843
[TBL] [Abstract][Full Text] [Related]
2. Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia.
Jayant S; Sharma B
Curr Neurovasc Res; 2016 Sep; ():. PubMed ID: 27599483
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective Effects of Nicorandil in Chronic Cerebral Hypoperfusion-Induced Vascular Dementia.
Gupta S; Singh P; Sharma B
J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2717-2728. PubMed ID: 27622862
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological modulation of I(1)-imidazoline and α2-adrenoceptors in sub acute brain ischemia induced vascular dementia.
Gupta S; Sharma B
Eur J Pharmacol; 2014 Jan; 723():80-90. PubMed ID: 24333661
[TBL] [Abstract][Full Text] [Related]
5. Modulation of transient receptor potential vanilloid subtype 1 (TRPV1) and norepinephrine transporters (NET) protect against oxidative stress, cellular injury, and vascular dementia.
Gupta S; Sharma B; Singh P; Sharma BM
Curr Neurovasc Res; 2014 May; 11(2):94-106. PubMed ID: 24597602
[TBL] [Abstract][Full Text] [Related]
6. Reversal in Cognition Impairments, Cholinergic Dysfunction, and Cerebral Oxidative Stress Through the Modulation of Ryanodine Receptors (RyRs) and Cysteinyl Leukotriene-1 (CysLT1) Receptors.
Singh P; Sharma B
Curr Neurovasc Res; 2016; 13(1):10-21. PubMed ID: 26500103
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Effects of Agomelatine and Vinpocetine Against Chronic Cerebral Hypoperfusion Induced Vascular Dementia.
Gupta S; Singh P; Sharma BM; Sharma B
Curr Neurovasc Res; 2015; 12(3):240-52. PubMed ID: 26036976
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of Endothelin (ETA and ETB) Receptors During Renovascular Hypertension-Induced Vascular Dementia Improves Cognition.
Singh P; Gupta S; Sharma B
Curr Neurovasc Res; 2016; 13(3):219-29. PubMed ID: 27189349
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of grape seed polyphenol extract restores memory deficits in chronic cerebral hypoperfusion rats.
Chen C; Zheng Y; Wu T; Wu C; Cheng X
Behav Pharmacol; 2017 Apr; 28(2 and 3-Spec Issue):207-213. PubMed ID: 27984208
[TBL] [Abstract][Full Text] [Related]
10. Melatonin receptor and KATP channel modulation in experimental vascular dementia.
Singh P; Gupta S; Sharma B
Physiol Behav; 2015 Apr; 142():66-78. PubMed ID: 25659733
[TBL] [Abstract][Full Text] [Related]
11. Carvacrol suppresses learning and memory dysfunction and hippocampal damages caused by chronic cerebral hypoperfusion.
Shahrokhi Raeini A; Hafizibarjin Z; Rezvani ME; Safari F; Afkhami Aghda F; Zare Mehrjerdi F
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):581-589. PubMed ID: 31729545
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimer's disease.
Jayant S; Sharma BM; Bansal R; Sharma B
Pharmacol Biochem Behav; 2016 Jan; 140():39-50. PubMed ID: 26577751
[TBL] [Abstract][Full Text] [Related]
13. Chronic cerebral hypoperfusion-induced memory impairment and hippocampal long-term potentiation deficits are improved by cholinergic stimulation in rats.
Damodaran T; Müller CP; Hassan Z
Pharmacol Rep; 2019 Jun; 71(3):443-448. PubMed ID: 31003155
[TBL] [Abstract][Full Text] [Related]
14. Edaravone injection reverses learning and memory deficits in a rat model of vascular dementia.
Li X; Lu F; Li W; Qin L; Yao Y; Ge X; Yu Q; Liang X; Zhao D; Li X; Zhang J
Acta Biochim Biophys Sin (Shanghai); 2017 Jan; 49(1):83-89. PubMed ID: 27864280
[TBL] [Abstract][Full Text] [Related]
15. Cinepazide Maleate Improves Cognitive Function and Protects Hippocampal Neurons in Diabetic Rats with Chronic Cerebral Hypoperfusion.
Li Y; Zhang T; Zhang X; Zou W; Gong X; Fu J
Biol Pharm Bull; 2017 Mar; 40(3):249-255. PubMed ID: 27990002
[TBL] [Abstract][Full Text] [Related]
16. Gastrodin improves cognitive dysfunction and decreases oxidative stress in vascular dementia rats induced by chronic ischemia.
Li Y; Zhang Z
Int J Clin Exp Pathol; 2015; 8(11):14099-109. PubMed ID: 26823723
[TBL] [Abstract][Full Text] [Related]
17. Melatonin improves cognitive function by suppressing endoplasmic reticulum stress and promoting synaptic plasticity during chronic cerebral hypoperfusion in rats.
Thangwong P; Jearjaroen P; Govitrapong P; Tocharus C; Tocharus J
Biochem Pharmacol; 2022 Apr; 198():114980. PubMed ID: 35219702
[TBL] [Abstract][Full Text] [Related]
18. Neurovascular integrative effects of long-term environmental enrichment on chronic cerebral hypoperfusion rat model.
Song MK; Kim YJ; Lee JM; Kim YJ
Brain Res Bull; 2020 Oct; 163():160-169. PubMed ID: 32711044
[TBL] [Abstract][Full Text] [Related]
19. The potential protective effects of cannabinoid receptor agonist WIN55,212-2 on cognitive dysfunction is associated with the suppression of autophagy and inflammation in an experimental model of vascular dementia.
Wang DP; Yin H; Kang K; Lin Q; Su SH; Hai J
Psychiatry Res; 2018 Sep; 267():281-288. PubMed ID: 29945070
[TBL] [Abstract][Full Text] [Related]
20. Baicalein improves cognitive deficits induced by chronic cerebral hypoperfusion in rats.
Liu C; Wu J; Gu J; Xiong Z; Wang F; Wang J; Wang W; Chen J
Pharmacol Biochem Behav; 2007 Mar; 86(3):423-30. PubMed ID: 17289131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
